• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4595230)   Today's Articles (0)   Subscriber (49331)
For: Gonzalez-Martin A, Gladieff L, Stroyakovskiy D, Tholander B, Gore M, Scambia G, Kristensen G, Diz M, Bollag D, Pignata S. 8002 ORAL Front-line Bevacizumab (BEV) Combined With Weekly Paclitaxel (wPAC) and Carboplatin (C) for Ovarian Cancer (OC): Safety Results From the Concurrent Chemotherapy (CT) Phase of the OCTAVIa Study. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)72090-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
Number Cited by Other Article(s)
1
Angiogenesis: A promising therapeutic target for ovarian cancer. Crit Rev Oncol Hematol 2012;84:314-26. [DOI: 10.1016/j.critrevonc.2012.04.002] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2012] [Revised: 03/31/2012] [Accepted: 04/10/2012] [Indexed: 12/16/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA